CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farnham, P. J.
Right arrow Articles by Kollmar, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farnham, P. J.
Right arrow Articles by Kollmar, R.

Cell Growth & Differentiation, Vol 1, Issue 4 179-189, Copyright © 1990 by American Association of Cancer Research


ARTICLES

Characterization of the 5' end of the growth-regulated Syrian hamster CAD gene

PJ Farnham and R Kollmar
McArdle Laboratory for Cancer Research, University of Wisconsin, Madison 53706.

The carbamoylphosphate synthetase-aspartate transcarbamylase-dihydroorotase (CAD) gene encodes a tri-functional protein catalyzing the first three steps in de novo pyrimidine biosynthesis. Studies correlating CAD gene expression with cellular proliferation indicate the importance of understanding the regulation of the CAD gene. As a first step, the structure of the promoter region of the Syrian hamster CAD gene has been determined. Sequence analysis of 1671 base pairs of DNA revealed that the CAD promoter region is very GC rich. Primer extension analysis indicated that the transcription initiation site of the CAD gene is downstream from two GC boxes (consensus binding sites for the transcription factor Sp1). There is no TATA box appropriately spaced upstream from the transcription initiation site. Using RNase protection mapping, S1 nuclease analysis, and comparison to consensus splice donor/acceptor sites, the 5' end of the CAD gene has been determined to consist of a 241-base pair first exon, a 187-base pair first intron, a 140-base pair second exon, and a second intron that extends at least three kilobase pairs. Using conditions optimized for this GC-rich promoter, accurate transcription can be achieved in vitro. Analysis of CAD promoter deletions indicated that sequences extending only 114 base pairs upstream and 225 base pairs downstream from the transcription initiation site are sufficient for accurate and efficient transcription in vitro. DNase I footprinting reactions using this promoter fragment have identified three regions that bind proteins in a HeLa nuclear extract.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
K. E. Boyd, J. Wells, J. Gutman, S. M. Bartley, and P. J. Farnham
c-Myc target gene specificity is determined by a post-DNAbinding mechanism
PNAS, November 10, 1998; 95(23): 13887 - 13892.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. M. Najjar, Y. R. Boisclair, Z. T. Nabih, N. Philippe, Y. Imai, Y. Suzuki, D.-S. Suh, and G. T. Ooi
Cloning and Characterization of a Functional Promoter of the Rat pp120 Gene, Encoding a Substrate of the Insulin Receptor Tyrosine Kinase
J. Biol. Chem., April 12, 1996; 271(15): 8809 - 8817.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
K M Hsiao, S L McMahon, and P J Farnham
Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
Genes & Dev., July 1, 1994; 8(13): 1526 - 1537.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1990 by the American Association of Cancer Research.